A recombinant baculovirus expressing glycoprotein H (gpUL75) of human cytomegalovirus was used to examine the humoral immune response in naturally infected individuals. Recombinant baculovirus infected insect cells produced two forms of gH with molecular masses of 78–82 kDa and 94 kDa. The 94 kDa polypeptide was modified by high mannose oligosaccharide side-chains as shown by reduction in molecular mass after treatment with endoglycosidases H and F. The 78–82 kDa protein represented the non-glycosylated precursor which was resistant to the enzymes. In contrast to gH expressed in mammalian cells, the recombinant baculovirus expressed gH was transported to the cell surface. Glycoprotein H produced in insect cells was reactive with human convalescent sera and all tested neutralizing monoclonal antibodies recognizing either linear or conformational epitopes. Antibodies reacting with insect cell derived gH were detected in 96% of HCMV seropositive human sera. Using insect cells infected with the gH expressing recombinant baculovirus as immunoabsorbent, between 0% and 58% of the total virus neutralizing activity was removed from sera of individuals with a past HCMV infection. gH must therefore be considered a major antigen for the induction of neutralizing antibodies during natural infection.
AdlerS. P.,
StarrS. E.,
PlotkinS. A.,
HempflingS. H.,
BuisJ.,
ManningM. L.,
BestA. M.1995; Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. Journal of Infectious Diseases 171:26–32
AndreoniM.,
FairclothM.,
VuglerL.,
BrittW. J.1989; A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. Journal of Virological Methods 23:157–167
BaboonianC.,
BlakeK.,
BoothJ. C.,
WiblinC. N.1989; Complement-independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus. Journal of Medical Virology 29:139–145
BeningaJ.,
KropffB.,
MachM.1995; Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. Journal of General Virology 76:153–160
BognerE.,
ReschkeM.,
ReisB.,
ReisE.,
BrittW.,
RadsakK.1992; Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Archives of Virology 126:67–80
BrittW. J.,
VuglerL. G.1992; Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). Journal of Virology 66:6747–6754
BrittW. J.,
VuglerL.,
ButfiloskiE. J.,
StephensE. B.1990; Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64:1079–1085
BrowneH.,
BaxterV.,
MinsonT.1993; Analysis of protective immune responses to the glycoprotein H–glycoprotein L complex of herpes simplex virus type 1. Journal of General Virology 74:2813–2817
ChouS. W.,
DennisonK. M.1991; Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. Journal of Infectious Diseases 163:1229–1234
CranageM. P.,
SmithG. L.,
BellS. E.,
HartH.,
BrownC.,
BankierA. T.,
TomlinsonP.,
BarrellB. G.,
MinsonT. C.1988; Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type I glycoprotein H. Journal of Virology 62:1416–1422
DuusK. M.,
HatfieldC.,
GroseC.1995; Cell surface expression and fusion by the varicella-zoster virus gH: gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210:429–440
EhrlichP. H.,
MoustafaZ. A.,
JusticeJ. C.,
HarfeldtK. E.,
OstbergL.1988; Further characterization of the fate of human monoclonal antibodies in rhesus monkeys. Hybridoma 7:385–395
Foa-TomasiL.,
AvitabileE.,
BoscaroA.,
BrandimartiR.,
GualandriR.,
ManservigiR.,
Dall’OlioF.,
Serafini-CessiF.,
FiumeG. C.1991; Herpes simplex virus (HSV) glycoprotein H is partially processed in a cell line that expresses the glycoprotein and fully processed in cells infected with deletion or ts mutants in the known HSV glycoproteins. Virology 180:474–482
ForresterA. J.,
SullivanV.,
SimmonsA.,
BlacklawsB. A.,
SmithG. L.,
NashA. A.,
MinsonA. C.1991; Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Journal of General Virology 72:369–375
FowlerK. B.,
StagnoS.,
PassR. F.,
BrittW. J.,
BollT. J.,
AlfordC. A.1992; The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [see comments]. New England Journal of Medicine 326:663–667
GhiasiH.,
NesburnA. B.,
WechslerS. L.1991; Cell surface expression of herpes simplex virus type I glycoprotein H in recombinant baculovirus-infected cells. Virology 185:187–194
GompelsU. A.,
MinsonA. C.1989; Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. Journal of Virology 63:4744–4755
GretchD. R.,
KariB.,
GehrzR. C.,
StinskiM. F.1988; A multigene family encodes the human cytomegalovirus glycoprotein complex gcll (gp47-52 complex). Journal of Virology 62:1956–1962
HutchinsonL.,
BrowneH.,
WargentV.,
Davis-PoynterN.,
PrimoracS.,
GoldsmithK.,
MinsonA. C.,
JohnsonD. C.1992; A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
JonjicS.,
PavicI.,
PolicB.,
CrnkovicI.,
LucinP.,
KoszinowskiU. H.1994; Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179:1713–1717
KayeJ. F.,
GompelsU. A.,
MinsonA. C.1992; Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73:2693–2698
KluppB. G.,
BaumeisterJ.,
KargerA.,
VisserN.,
MettenleiterT. C.1994; Identification and characterization of a novel structural glycoprotein in pseudorabies virus. gL. Journal of Virology 68:3868–3878
KurodaK.,
GeyerH.,
GeyerR.,
DoerflerW.,
KlenkH. D.1990; The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology 174:418–429
LiuD. X.,
CompelsU. A.,
Foa-TomasiL.,
Campadelli-FiumeG.1993; Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197:12–22
LuckowV. A.,
SummersM. D.1988; Signals important for high-level expression of foreign genes in Autographa califomica nuclear polyhedrosis virus expression vectors. Virology 167:56–71
MarshallG. S.,
RabalaisG. P.,
StoutG. G.,
WaldeyerS. L.1992; Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. Journal of Infectious Diseases 165:381–384
RappM.,
MesserleM.,
LucinP.,
KoszinowskiU. H.1993; In vivo protection studies with MCMV glycoproteins gB and gH expressed by vaccinia virus. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease pp 327–332 Edited by
MichelsonS.,
PlotkinS. A.
Amsterdam: Excerpta Medica;
RasmussenL.1993; Progress in the development of a human cytomegalovirus glycoprotein subunit vaccine. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease pp 311–320 Edited by
MichelsonS.,
PlotkinS. A.
Amsterdam: Excerpta Medica;
RasmussenL. E.,
NelsonR. M.,
KelsallD. C.,
MeriganT. C.1984; Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proceedings of the National Academy of Sciences, USA 81:876–880
RasmussenL.,
MatkinC.,
SpaeteR.,
PaehlC.,
MeriganT. C.1991; Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. Journal of Infectious Diseases 164:835–842
ReusserP.,
RiddellS. R.,
MeyersJ. D.,
GreenbergP. D.1991; Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373–1380
RiddellS. R.,
GreenbergP. D.1994; Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. Current Topics in Microbiology and Immunology 189:9–34
RobertsS. R.,
Ponce de-LeonM.,
CohenG. H.,
EisenbergR. J.1991; Analysis of the intracellular maturation of the herpes simplex virus type I glycoprotein gH in infected and transfected cells. Virology 184:609–624
RoyD. M.,
GrundyJ. E.,
EmeryV. C.1993; Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients. Journal of General Virology 74:2499–2505
SimpsonJ. A.,
ChowJ. C.,
BakerJ.,
AvdalovicN.,
YuanS.,
AuD.,
CoM. S.,
VasquezM.,
BrittW. J.,
CoelinghK. L.1993; Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites. Journal of Virology 67:489–496
SpaeteR. R.,
PerotK.,
ScottP. I.,
NelsonJ. A.,
StinskiM. F.,
PachlC.1993; Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193:853–861
UrbanM.,
BrittW.,
MachM.1992; The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. Journal of Virology 66:1303–1311
UrbanM.,
WinklerT.,
LandiniM. P.,
BrittW.,
MachM.1994; Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. Journal of Infectious Diseases 169:83–90
UtzU.,
BrittW.,
VuglerL.,
MachM.1989; Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63:1995–2001
WellsD. E.,
VuglerL. G.,
BrittW. J.1990; Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells. Journal of General Virology 71:873–880
YaswenL. R.,
StephensE. B.,
DavenportL. C.,
Hutt-FletcherL. M.1993; Epstein–Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195:387–396